File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1371/journal.pone.0010864
- Scopus: eid_2-s2.0-77956503084
- PMID: 20532246
- WOS: WOS:000278221900014
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus.
Title | Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus. | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Authors | |||||||||||
Issue Date | 2010 | ||||||||||
Publisher | Public Library of Science. The Journal's web site is located at http://www.plosone.org/home.action | ||||||||||
Citation | Plos One, 2010, v. 5 n. 5, p. e10864 How to Cite? | ||||||||||
Abstract | BACKGROUND: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-infected patients with severe clinical illness or asymptomatic infection. METHODS: Using H5N1 microneutralisation (MN) and H5-pseudotype particle-based microneutralisation assays (H5pp) we analyzed sera sequentially obtained from 11 severely ill patients diagnosed by RT-PCR (follow-up range 1-139 weeks of disease onset) and 31 asymptomatically infected individuals detected in a sero-epidemiological study after exposure to H5N1 virus (follow-up range: 1-2 month-11 months after exposure). RESULTS: Of 44 sera from 11 patients with H5N1 disease, 70% tested positive by MN (antibody titre > or = 80) after 2 weeks and 100% were positive by 3 weeks after disease onset. The geometric mean MN titers in severely ill patients were 540 at 1-2 months and 173 at 10-12 months and thus were higher than the titers from asymptomatic individuals (149 at 1-2 months, 62.2 at 10-12 months). Fractional polynomial regression analysis demonstrated that in all severely ill patients, positive titers persisted beyond 2 years of disease onset, while 10 of 23 sera collected 10-11 months after exposure in asymptomatically infected individuals tested negative. CONCLUSIONS: Our results indicate that people with asymptomatic H5N1 infection have lower H5N1 antibody titres compared to those with severe illness and that in many asymptomatically infected patients the antibody titer decreased to levels below the threshold of positivity within one year. These data are essential for the design and interpretation of sero-epidemiological studies. | ||||||||||
Persistent Identifier | http://hdl.handle.net/10722/129962 | ||||||||||
ISSN | 2023 Impact Factor: 2.9 2023 SCImago Journal Rankings: 0.839 | ||||||||||
PubMed Central ID | |||||||||||
ISI Accession Number ID |
Funding Information: This work was supported by a grant from the AFD (French Agency for Development, SISEA project, RESPARI program, http://www.pasteurinternational.org/ip/easysite/pasteur-international-en/scientific-activities/projects/all-our-projects/sisea), by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, by the Area of Excellence Scheme of the University Grants Committee, Hong Kong (Grant AoE/M-12/06), and by the Wellcome Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. | ||||||||||
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Buchy, P | en_HK |
dc.contributor.author | Vong, S | en_HK |
dc.contributor.author | Chu, S | en_HK |
dc.contributor.author | Garcia, JM | en_HK |
dc.contributor.author | Hien, TT | en_HK |
dc.contributor.author | Hien, VM | en_HK |
dc.contributor.author | Channa, M | en_HK |
dc.contributor.author | Ha, Q | en_HK |
dc.contributor.author | Chau, NV | en_HK |
dc.contributor.author | Simmons, C | en_HK |
dc.contributor.author | Farrar, JJ | en_HK |
dc.contributor.author | Peiris, M | en_HK |
dc.contributor.author | de Jong, MD | en_HK |
dc.date.accessioned | 2010-12-23T08:44:50Z | - |
dc.date.available | 2010-12-23T08:44:50Z | - |
dc.date.issued | 2010 | en_HK |
dc.identifier.citation | Plos One, 2010, v. 5 n. 5, p. e10864 | en_HK |
dc.identifier.issn | 1932-6203 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/129962 | - |
dc.description.abstract | BACKGROUND: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-infected patients with severe clinical illness or asymptomatic infection. METHODS: Using H5N1 microneutralisation (MN) and H5-pseudotype particle-based microneutralisation assays (H5pp) we analyzed sera sequentially obtained from 11 severely ill patients diagnosed by RT-PCR (follow-up range 1-139 weeks of disease onset) and 31 asymptomatically infected individuals detected in a sero-epidemiological study after exposure to H5N1 virus (follow-up range: 1-2 month-11 months after exposure). RESULTS: Of 44 sera from 11 patients with H5N1 disease, 70% tested positive by MN (antibody titre > or = 80) after 2 weeks and 100% were positive by 3 weeks after disease onset. The geometric mean MN titers in severely ill patients were 540 at 1-2 months and 173 at 10-12 months and thus were higher than the titers from asymptomatic individuals (149 at 1-2 months, 62.2 at 10-12 months). Fractional polynomial regression analysis demonstrated that in all severely ill patients, positive titers persisted beyond 2 years of disease onset, while 10 of 23 sera collected 10-11 months after exposure in asymptomatically infected individuals tested negative. CONCLUSIONS: Our results indicate that people with asymptomatic H5N1 infection have lower H5N1 antibody titres compared to those with severe illness and that in many asymptomatically infected patients the antibody titer decreased to levels below the threshold of positivity within one year. These data are essential for the design and interpretation of sero-epidemiological studies. | en_HK |
dc.language | eng | en_US |
dc.publisher | Public Library of Science. The Journal's web site is located at http://www.plosone.org/home.action | en_HK |
dc.relation.ispartof | PLoS ONE | en_HK |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject.mesh | Antibodies, Neutralizing - immunology | - |
dc.subject.mesh | Antibodies, Viral - immunology | - |
dc.subject.mesh | Kinetics | - |
dc.subject.mesh | Influenza A Virus, H5N1 Subtype - classification - immunology | - |
dc.subject.mesh | Influenza, Human - blood - immunology | - |
dc.title | Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus. | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Peiris, M: malik@hkucc.hku.hk | en_HK |
dc.identifier.authority | Peiris, M=rp00410 | en_HK |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1371/journal.pone.0010864 | en_HK |
dc.identifier.pmid | 20532246 | - |
dc.identifier.pmcid | PMC2879427 | - |
dc.identifier.scopus | eid_2-s2.0-77956503084 | en_HK |
dc.identifier.hkuros | 178065 | en_US |
dc.identifier.volume | 5 | en_HK |
dc.identifier.issue | 5 | en_HK |
dc.identifier.spage | e10864 | en_HK |
dc.identifier.epage | e10864 | en_HK |
dc.identifier.isi | WOS:000278221900014 | - |
dc.publisher.place | United States | en_HK |
dc.relation.project | Control of Pandemic and Inter-pandemic Influenza | - |
dc.identifier.scopusauthorid | Buchy, P=15019240000 | en_HK |
dc.identifier.scopusauthorid | Vong, S=6603420595 | en_HK |
dc.identifier.scopusauthorid | Chu, S=36243207900 | en_HK |
dc.identifier.scopusauthorid | Garcia, JM=16202601400 | en_HK |
dc.identifier.scopusauthorid | Hien, TT=7005271267 | en_HK |
dc.identifier.scopusauthorid | Hien, VM=10043209900 | en_HK |
dc.identifier.scopusauthorid | Channa, M=36097732200 | en_HK |
dc.identifier.scopusauthorid | Ha, Q=7101767746 | en_HK |
dc.identifier.scopusauthorid | Chau, NV=23007606000 | en_HK |
dc.identifier.scopusauthorid | Simmons, C=7103173872 | en_HK |
dc.identifier.scopusauthorid | Farrar, JJ=7103292979 | en_HK |
dc.identifier.scopusauthorid | Peiris, M=7005486823 | en_HK |
dc.identifier.scopusauthorid | de Jong, MD=7201366838 | en_HK |
dc.identifier.issnl | 1932-6203 | - |